Compound ID | 2104
Class: Small molecule antibacterial agent
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Interferes with cell-wall synthesis by inhibiting transfer of the peptidoglycan precursor moiety (MurNAc-pentapeptide) to the membrane lipid carrier, undecaprenyl phosphate; MraY inhibitor |
| Description: | Semisynthetic amphomycin derivative |
| Year first mentioned: | 2006 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/500839928 |
| Guide to Pharmacology: | MX-2401 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101398/ |